Word: molecular
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...among theologians and biologists, and a Communications Office—and yet there was no rebuttal even to an ignorant Associated Press story last year, headlined “Harvard Joins Evolution Debate,” which implied that Harvard researchers’ work on the origins of raw molecular rudiments had something to do with science’s account of the origins of species. A more spectacular example of willful wrongness involves elementary textual interpretation. The U.S.’ current executive branch is working under a dead-wrong theory about the nature of its power...
...Hall on May 4, awarded the TF award to Sebastian Velez of the Department of Organismic and Evolutionary Biology, the junior faculty award to Lynn Mary Festa, who is the Cowles associate professor of English and American literature and language, and Glenn Adelson, who is a teaching assistant in molecular and cellular biology. The senior faculty award went to Watts Professor of Music Kay K. Shelemay...
Meanwhile, the pharmaceutical industry has been developing insulin analogues, molecular variations of human insulin that are absorbed more predictably. The new products could be highly profitable, but I'm not convinced that they have significant advantages over animal insulin. I suspect drugmakers are dropping animal insulin because it is not sufficiently profitable. More money can be made from genetically engineered insulin and even more from fancy analogues...
...member of the Life Sciences Education Committee. Current freshmen will be able to choose among established life science concentrations—Biology, Biochemical Sciences, Chemistry, and Biological Anthropology—as well as five new concentration clusters, Chemical and Physical Biology, Human Evolutionary Biology, Molecular and Cellular Biology, Neurobiology, and Organismic and Evolutionary Biology. Life science concentrators may also choose to pursue the Social and Cognitive Neuroscience track within psychology. “We’ve designed the concentrations to make it better, based largely on what students are telling us,” Lieberman said...
...recent paper said more than 200 compounds use NF-kB signaling, aspirin among them. “NF-kB ought to be available to anybody who wants to make a drug against it, and the terms should not be unreasonable,” Roger Brent, president of the nonprofit Molecular Sciences Institute, told Science. “It’s potentially quite significant, although I think Ariad’s going to lose,” Rai said in an interview yesterday. A decision from the jury is expected on May 1 or shortly therafter, according to Eli Lilly...